| Original language | English (US) |
|---|---|
| Article number | 100759 |
| Journal | EClinicalMedicine |
| Volume | 33 |
| DOIs |
|
| State | Published - Mar 2021 |
ASJC Scopus subject areas
- General Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: EClinicalMedicine, Vol. 33, 100759, 03.2021.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Executive summary
T2 - It's wrong not to test: The case for universal, frequent rapid COVID-19 testing
AU - Rapid Tests Working Group
AU - Johnson-León, Maureen
AU - Caplan, Arthur L.
AU - Kenny, Louise
AU - Buchan, Iain
AU - Fesi, Leah
AU - Olhava, Phoebe
AU - Nsobila Alugnoa, Desmond
AU - Aspinall, Mara G.
AU - Costanza, Emily
AU - Desharnais, Brianna
AU - Price, Corinne
AU - Frankle, Jon
AU - Binding, Jonas
AU - Ramirez, Cherie Lynn
N1 - Funding Information: The authors declare that they do not have any manifest conflict of interest. Dr. Buchan reports personal fees and other from his service as Chief Data Scientist Advisor to AstraZeneca and a grant from the National Institute for Health Research (NIHR), all outside the submitted work. Ms. Aspinall reports that she is compensated for her service on the Boards of Directors of both Orasure and Abcam as well as for serving as an Advisor to Cepheid. Dr. Binding reports that he works for Robert Bosch GmbH. There is a separate division within the company producing and selling rapid PCR tests for SARS-CoV-2 ("Vivalytics"). He declares that he has no work ties with that team. Funding Information: We thank the following collaborators for their invaluable contributions to this work: Emerging Infectious Disease (EID) Policy Researcher Mary Marshall, Mr. Ishaan Desai, Mr. Steven S. Ross, Dr. Joseph DeRisi, Dr. Robert Klitzman, Dr. Irene Petersen, Dr. Chris Said, & Dr. Michael Mina. Ms. Costanza was supported by the Simmons University Fund for Undergraduate Research and Creative Endeavors. Ms. Desharnais was supported by the Summer Undergraduate Research Program at Simmons (SURPASs). This commentary is dedicated to the practitioners, researchers, policymakers, and everyday people whose courage and perseverance have made possible the body of knowledge that informs our work.
PY - 2021/3
Y1 - 2021/3
UR - http://www.scopus.com/inward/record.url?scp=85101068271&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101068271&partnerID=8YFLogxK
U2 - 10.1016/j.eclinm.2021.100759
DO - 10.1016/j.eclinm.2021.100759
M3 - Comment/debate
AN - SCOPUS:85101068271
SN - 2589-5370
VL - 33
JO - EClinicalMedicine
JF - EClinicalMedicine
M1 - 100759
ER -